As of 2025-07-06, the Intrinsic Value of Immunovant Inc (IMVT) is -12.18 USD. This IMVT valuation is based on the model Peter Lynch Fair Value. With the current market price of 16.95 USD, the upside of Immunovant Inc is -171.87%.
Based on its market price of 16.95 USD and our intrinsic valuation, Immunovant Inc (IMVT) is overvalued by 171.87%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.18 - -12.18 | -12.18 | -171.87% |
| P/E | (33.38) - (65.78) | (52.69) | -410.8% |
| DDM - Stable | (12.25) - (27.43) | (19.84) | -217.1% |
| DDM - Multi | (1.08) - (1.92) | (1.38) | -108.2% |
| Market Cap (mil) | 2,879.13 |
| Beta | 0.92 |
| Outstanding shares (mil) | 169.86 |
| Enterprise Value (mil) | 2,165.16 |
| Market risk premium | 4.60% |
| Cost of Equity | 14.96% |
| Cost of Debt | 5.00% |
| WACC | 9.98% |